Arkolith/Insider Trading/KROS/Form 4

Pontifax (China) IV L.P.

10% OwnerKeros Therapeutics, Inc. (KROS) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$85.0M
Net Open-Market Flow
-$85.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)2.3M$17.75$40.6M0
Oct 15, 2025Sell(S)155K$17.75$2.8M0
Oct 15, 2025Sell(S)1.2M$17.75$21.8M0
Oct 15, 2025Sell(S)1.1M$17.75$19.9M0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-002765) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML